Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
<p>Abstract</p> <p>Background</p> <p>To compare the periodical incidence rates of genitourinary (GU) and gastrointestinal (GI) toxicity in patients who underwent prostate low-dose-rate brachytherapy between the monotherapy group (seed implantation alone) and the boost g...
Main Authors: | Tanaka Nobumichi, Asakawa Isao, Anai Satoshi, Hirayama Akihide, Hasegawa Masatoshi, Konishi Noboru, Fujimoto Kiyohide |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://www.ro-journal.com/content/8/1/25 |
Similar Items
-
Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
by: Tanaka Nobumichi, et al.
Published: (2012-09-01) -
Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D2cc: A single-institution, retrospective review
by: Neil D. Wallace, et al.
Published: (2023-03-01) -
Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer
by: Nobumichi Tanaka, et al.
Published: (2017-08-01) -
Brachytherapy in paediatric malignancies – review of indications
by: Jacek Fijuth
Published: (2010-07-01) -
Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer
by: Yasushi Nakai, et al.
Published: (2019-09-01)